RARS1 and breast carcinoma: In the above-cited paper of Schug and co-workers was reported that in the ATRA-resistant mouse model of breast cancer MMTV-neu, ATRA activated the non-classical pro-survival pathway binding to PPARβ/δ instead of RARs (see Section 3.2.1; Figure 3) [75].